Learn More
BRRN1Rabbit anti-Human, Polyclonal, Rockland™

Description
Store vial at -20°C prior to opening. Aliquot contents and freeze at -20°C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. Reactivity occurs against human BRRN1 protein. However, BLAST analysis indicates 100% homology (18/18) for this protein from human, and chimpanzee. Partial cross reactivity is expected against mouse, dog, rat chicken, and from based on sequence homology of the amino terminal 13 amino acids of the immunogen sequence. The core 8 amino acids of the immunogen, A-G-P-D-H-W-R-F, show 100% identity with numerous proteins from a variety of organisms. If blots show multiple banding patterns in any particular lysate, it is suggested to confirm the specific reactivity against the BRRN1 protein using peptide competition. Reactivity with Brnn1 proteins from other sources is not known.
Specifications
Specifications
| Antigen | BRRN1 |
| Applications | ELISA, Immunoprecipitation, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.93 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.02M potassium phosphate with 0.15M NaCl and 0.01% sodium azide; pH 7.2 |
| Gene | NCAPH |
| Gene Accession No. | Q15003 |
| Gene Alias | A730011O11Rik; barren homolog 1; Barren homolog protein 1; BRRN; Brrn1; Caph; CAP-H; Chromosome-associated protein H; Condensin complex subunit 2; hCAP-H; KIAA0074; mCAP-H; mKIAA0074; NCAPH; Non-SMC condensin I complex subunit H; non-SMC condensin I complex, subunit H; XCAP-H homolog |
| Gene Symbols | NCAPH |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.